Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-monthly intravenous MIRCERA for maintenance of hemoglobin in dialysis patients with chronic renal anemia
2006-006349-15Phase 3Completed
- Sponsor
- Roche
- Start
- Jun 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Epoetin alfa RB in anemia of renal disease and anemia of chronic kidney disease, sponsored by Roche. Started Jun 2007; status: completed.
02
Drugs
Epoetin alfa RB
03
Conditions
anemia of renal diseaseanemia of chronic kidney disease
Beyond the preview
Go deeper on 2006-006349-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006349-15.